Organigram Global (OGI) Liabilities from Discontinued Operations (2018)
Organigram Global (OGI) posted quarterly Liabilities from Discontinued Operations of 49644.39 for Q3 2018.
Organigram Global (OGI) Liabilities from Discontinued Operations (2018) Analysis & Trends
Organigram Global (OGI) has reported Liabilities from Discontinued Operations for 1 consecutive years, with 49644.39 the latest figure, recorded in Q3 2018.
- In Q3 2018, Liabilities from Discontinued Operations changed N/A year-over-year to 49644.39; the TTM figure through Aug 2018 stood at 49644.39 (changed N/A YoY), while the FY2018 annual figure was 50917.42, changed N/A from the prior year.
- Liabilities from Discontinued Operations held at 49644.39 in Q3 2018 per OGI's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at 49644.39 in Q3 2018 and bottomed at 49644.39 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Organigram Global | 150.72 Mn | 150.60 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2018 | 49,644.39 |
| Aug 31, 2018 | 49,644.39 |